264 related articles for article (PubMed ID: 31562534)
1. High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.
Lu K; Feng F; Yang Y; Liu K; Duan J; Liu H; Yang J; Wu M; Liu C; Chang Y
J Gastroenterol; 2020 Jan; 55(1):51-66. PubMed ID: 31562534
[TBL] [Abstract][Full Text] [Related]
2. MiR-20a triggers metastasis of gallbladder carcinoma.
Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
[TBL] [Abstract][Full Text] [Related]
4. Identification of invasion-metastasis associated MiRNAs in gallbladder cancer by bioinformatics and experimental validation.
Cao J; Shao H; Hu J; Jin R; Feng A; Zhang B; Li S; Chen T; Jeungpanich S; Topatana W; Tian Y; Lu Z; Cai X; Chen M
J Transl Med; 2022 Apr; 20(1):188. PubMed ID: 35484565
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.
Hu YP; Jin YP; Wu XS; Yang Y; Li YS; Li HF; Xiang SS; Song XL; Jiang L; Zhang YJ; Huang W; Chen SL; Liu FT; Chen C; Zhu Q; Chen HZ; Shao R; Liu YB
Mol Cancer; 2019 Nov; 18(1):167. PubMed ID: 31752906
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNAs associated with the survival of patients with gallbladder carcinoma.
Wang J; Jin Y; Li S; Song Q; Tang P
J Int Med Res; 2020 May; 48(5):300060520918061. PubMed ID: 32406793
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression.
Ji T; Gao L; Yu Z
Cancer Gene Ther; 2021 Jun; 28(6):693-705. PubMed ID: 33250514
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
9. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
10. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.
Wang SH; Ma F; Tang ZH; Wu XC; Cai Q; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
J Exp Clin Cancer Res; 2016 Oct; 35(1):160. PubMed ID: 27716361
[TBL] [Abstract][Full Text] [Related]
12. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
Zhang X; Zhang L; Chen M; Liu D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
[TBL] [Abstract][Full Text] [Related]
13. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
[TBL] [Abstract][Full Text] [Related]
14. Low Expression of MicroRNA335-5p Is Associated with Malignant Behavior of Gallbladder Cancer: A Clinicopathological Study.
Fatima N; Srivastava AN; Nigam J; Raza ST; Rizvi S; Siddiqui Z; Kumar V
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1895-1900. PubMed ID: 31244315
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA aberrations: An emerging field for gallbladder cancer management.
Chandra V; Kim JJ; Mittal B; Rai R
World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
[TBL] [Abstract][Full Text] [Related]
16. Identification of cell cycle as the critical pathway modulated by exosome-derived microRNAs in gallbladder carcinoma.
Su L; Zhang J; Zhang X; Zheng L; Zhu Z
Med Oncol; 2021 Oct; 38(12):141. PubMed ID: 34655361
[TBL] [Abstract][Full Text] [Related]
17. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
Jin YP; Hu YP; Wu XS; Wu YS; Ye YY; Li HF; Liu YC; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu XY; Liu YB
Cell Death Dis; 2018 Feb; 9(2):182. PubMed ID: 29416013
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]